Patricia M Davis

Title: The Innovative Contributions of Patricia M. Davis

Introduction

Patricia M. Davis is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of DNA molecules and their applications in medicine. His work focuses on the development of novel therapeutic strategies for various diseases.

Latest Patents

Patricia M. Davis holds 1 patent for his invention titled "DNA molecules encoding human CLAX proteins and their soluble fusion proteins." This patent provides isolated novel cDNA sequences encoding a human C-type lectin and three homologues, collectively referred to as "CLAX" (C-type Lectin, Activation Expressed) proteins. The invention includes methods for utilizing these nucleic acid sequences, polypeptides, fusion proteins, antibodies specific for the novel CLAXs, as well as ligands and inhibitors. The genes of CLAX are specifically expressed in lymphoid tissues and activated T lymphocytes, but not in resting T lymphocytes. This invention has potential applications in pharmaceutical compositions for the prevention and treatment of infectious, inflammatory, and allergic diseases.

Career Highlights

Patricia M. Davis is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work has contributed to the understanding of immune responses and the development of targeted therapies.

Collaborations

Throughout his career, Patricia has collaborated with esteemed colleagues such as Guchen Yang and Xiaorong Chen. These collaborations have further enhanced the impact of his research in the scientific community.

Conclusion

Patricia M. Davis is a distinguished inventor whose work in biotechnology has the potential to revolutionize treatments for various diseases. His innovative contributions continue to shape the future of medical research and therapeutic development.